Concurrent expressions of metallothionein, glutathione S-transferase-π, and P-glycoprotein colorectal cancers

Diseases of the Colon and Rectum

Volumn 43, Issue 2, 2000, Pages 221-232

  Sutoh, Ichiro ^a,b   Kohno, Hitoshi ^a   Nakashima, Yuuichi ^a   Hishikawa, Yoshitaka ^a   Tabara, Hideki ^a   Tachibana, Mitsuo ^a   Kubota, Hirofumi ^a   Nagasue, Naofumi ^a  

^a SHIMANE UNIVERSITY   (Japan)

^b Unnan Municipal General Hospital   (Japan)

Author keywords

Adjuvant chemotherapy; Colorectum; Glutathione S transferase ; Metallothionein; P glycoprotein

Indexed keywords

ANTINEOPLASTIC AGENT; GLUTATHIONE TRANSFERASE; GLYCOPROTEIN; METALLOTHIONEIN;

ADULT; AGED; ARTICLE; CANCER ADJUVANT THERAPY; CANCER CHEMOTHERAPY; CANCER STAGING; CANCER SURVIVAL; COLORECTAL CANCER; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MALE; PROTEIN EXPRESSION;

EID: 0034009956     PISSN: 00123706     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF02236987     Document Type: Article

References (66)

1. Nortenius H. Human Oncology. Vol. 1. Baltimore: Urban & Schwarzenberg, 1988;319-69.
2. Pinedo HM. Drug resistance, illustration of the complexity of translational research. Steiner award lecture 1995. Int J Cancer 1996;65:561-6.
3. Basu A, Lazo JS. A hypothesis regarding the protective role of metallothioneins against the toxicity of DNA interactive anticancer drugs. Toxicol Lett 1990;50:123-35.
4. Kenneth DT. Glutathione-associated enzymes in anticancer resistance. Cancer Res 1994;54:4313-20
5. Germann UA. P-glycoprotein-A mediator of multidrug resistant in tumor cell. Eur J Cancer 1996;32A:927-44.
6. Bosch I, Croop J. P-glycoprotein multidrug resistance and cancer. Biochim Biophys Acta 1996;1288:37-54.
7. Loe DW, Deeley RG, Cole SPC. Biology of the multidrug resistance-associated protein, MRP. Eur J Cancer 1996; 32A:945-57.
8. Nitiss JL, Beck WT. Antitopoisomerase drug action and resistance. Eur J Cancer 1996;32A:958-66.
9. Kille P, Hemmings A, Lunney EA. Memories of metallothionein. Biochim Biophys Acta 1994;1205:151-61.
10. Aschner M. The functional significance of brain metallothioneins. FASEB J 1996;10:1129-36.
11. Quaife CJ, Findley SD, Erickson JC, et al. Induction of a new metallothionein isoform (MT-IV) occurs during differentiation of stratified squamous epithelia. Biochemistry 1994;33:7250-9.
12. Kelley SL, Basu A, Teicher BA, Hacker MP, Hamer DH, Lazo JS. Overexpression of metallothionein confers resistance to anticancer drugs. Science 1988;241:1813-5.
13. Lohrer H, Robson T. Overexpression of metallothionein in CHO cells and its effect on cell killing by ionizing radiation and alkylating agents. Carcinogenesis 1989;10: 2279-84.
14. Waxman DJ. Glutathione S-transferases. Role in alkylating agent resistance and possible target for modulation chemotherapy-A review. Cancer Res 1990;50:6449-54.
15. Dirven HA, Dictus EL, Broeders NL, Ommen B, Bladeren PJ. The role of human glutathione S-transferase isoenzymes in the formation of glutathione conjugates of the alkylating cytostatic drug thiotepa. Cancer Res 1995;55:1701-6.
16. Miyazaki M, Kohno K, Saburi Y, et al. Drug resistance to cis-diammine-dichloroplatinum (II) in Chinese hamster ovary cell lines transfected with glutathione S-transferase pi gene. Biochem Biophys Res Commun 1990;166:1358-64.
17. Okuyama T, Maehara Y, Endo K, et al. Expression of glutathione S-transferase-pi and sensitivity of human gastric cancer cells to cisplatin. Cancer 1994;74:1230-6.
18. Nishimura T, Newkirk K, Sessions RB, et al. Immunohistochemical staining for glutathione S-transferase predict response to platinum-based chemotherapy in head and neck cancer. Clin Cancer Res 1996;2:1859-1865.
19. Peters WH, Roelofs HM, Nagengast FM, Tongeren JH. Human intestinal glutathione S-transferase. Biochem J 1989;257:471-6.
20. Moorghen M, Cairns J, Forrester LM, et al. Enhanced expression of glutathione S-transferases in colorectal carcinoma compared to non-neoplastic mucosa. Carcinogenesis 1991;12:13-7.
21. Peters WH, Boon CE, Roelofs HM, Webbes T, Nagengast FM, Kremers PG. Expression of drug-metabolizing enzymes and P-170 glycoprotein in colorectal carcinoma and normal mucosa. Gastroenterology 1992;102: 448-55.
22. Satoh K, Kitahara A, Soma Y, Inaba Y, Hatayama I, Sato K. Purification, induction, and distribution of placental glutathione transferase: a new marker enzyme for preneoplastic cells in the rat chemical hepatocarcinogenesis. Proc Natl Acad Sci U S A 1985;82:3964-8.
23. Sherman M, Campbell AH, Titmuss SA, Kew MC, Kirsch RE. Glutathione S-transferase in human hepatocellular carcinoma. Hepatology 1983;3:170-6.
24. Kodate C, Fukushi A, Narita T, Kudo H, Soma Y, Sato K. Human placental form of glutathione S-transferase (GST-π) as a new immunohistochemical marker for human colonie carcinoma. Jpn J Cancer 1986;77:226-9.
25. Tsuchida S, Sekine Y, Shineha R, Nishihira T, Sato K. Elevation of the placental glutathione S-transferase form (GST-π) in tumor tissues and the levels in sera of patients with cancer. Cancer Res 1989;49:5225-9.
26. Juliano RL, Ling V. A surface glycoprotein modulating drug permeability in Chinese hamster ovary cell mutants. Biochim Biophys Acta 1976;455:152-62.
27. Cordon-Cardo C, O'brien JP, Casals BD, Bertino JR, Melamed MR. Expression of the multidrug resistance gene product (p-glycoprotein) in human normal and tumor tissues. J Histochem Cytochem 1990;38:1277-87.
28. Alvarez M, Paull K, Monks A, et al. Generation of a drug resistance profile by quantitation of mdr-1/p-glycoprotein in the cell lines of the national cancer institute anticancer drug screen. J Clin Invest 1995;95: 2205-14.
29. Fojo AT, Ueda K, Slamon DJ, Poplack DG, Gottesman MM, Pastan I. Expression of a multidrug-resistance gene in human tumors and tissues. Proc Natl Acad Sci U S A 1987;84:265-9.
30. Wu L, Smythe AM, Stinson SF, et al. Multidrug-resistant phenotype of disease-oriented panels of human tumor cell lines used for anticancer drug screening. Cancer Res 1992;52:3029-34.
31. Yang L-Y, Trujillo JM, Siciliano MJ, Kido Y, Siddik ZH, Su Y-Z. Distinct P-glycoprotein expression in two subclones simultaneously selected from a human colon carcinoma cell line by cis-diamminedichloro-platinum (II). Int J Cancer 1993;53:478-85.
32. Chao CC-K, Huang Y-T, Ma CM, Chou W-Y, Lin-Chao S. Overexpression of glutathione S-transferase and elevation of thiol pools in a multidrug-resistant human colon cancer cell line. Mol Pharmacol 1992;41:69-75.
33. Satta T, Isobe K, Yamauchi M, Nakasima I, Takagi H. Expression of MDR1 and glutathione S-transferase-π genes and chemosensitivities in human gastrointestinal cancer. Cancer 1992;69:941-6.
34. 6-alkylguanine-DNA alkyltransferase as potential indicators of constructive drug resistance in human colorectal tumors. Cancer Res 1991;51:2092-7.
35. Dukes CE. The classification of cancer of the rectum. J Pathol 1932;35:323-32.
36. Hsu SM, Raine L, Fanger H. Use of avidin-biotin-peroxidase technique: a comparison between ABC and unlabeled antibody (PAP) procedures. J Histochem Cytochem 1981;29:577-81.
37. Sincrope FA, Hart J, Brasitus TA, Michelassi F, Lee J, Safa AR. Relationship of p-glycoprotein and carcinoembryonic antigen expression in human colon carcinoma to local invasion, DNA ploidy, and disease relapse. Cancer 1994;74:2908-17.
38. Hishikawa Y, Abe S, Kinugasa S, et al. Overexpression of metallothionein correlates with chemoresistance to cisplatin and prognosis in esophageal cancer. Oncology 1997;54:342-7.
39. Monden N, Abe S, Sutoh I, Hishikawa Y, Kinugasa S, Nagasue N. Prognostic significance of the expressions of metallothionein, glutathione S-transferase-π, and P-glycoprotein in curatively resected gastric cancer. Oncology 1997;54:391-9.
40. Dolfini E, Dasdia T, Arancia G, et al. Characterization of clonal colon adenocarcinoma line intrinsically resistant to doxorubicin. Br J Cancer 1997;76:67-76.
41. Dolfini E, Dasdia T, Perletti G, et al. Analysis of calcium-dependent protein kinase-C isoenzymes in intrinsically resistant cloned lines of LoVo cells. Reversal of resistance by kinase inhibitor 1-(5-isoquinolinylsulfonyl)2-methylpiperazine. Anticancer Res 1993;13:1123-8.
42. Slovak ML, Coccia M, Meltzer PS, Trent JM. Molecular analysis of two human doxorubicin-resistant cell lines: evidence for differing multidrug resistance mechanisms. Anticancer Res 1991;11:423-8.
43. Dong Z, Ward NE, Fan D, Gupta KP, O'brien CA. In vitro model for intrinsic drug resistance: effects of protein kinase C activators on the chemosensitivity of cultured human colon cancer cells. Mol Pharmacol 1991; 39:563-9.
44. Friedman E, Isaksson P, Rafter J, Marian B, Winawer S, Newmark H. Fecal diglycerides as selective endogenous mitogen for premalignant and malignant human colonic epithelial cells. Cancer Res 1989;49:544-8.
45. Bakka A, Endersen L, Johnsen AB, Edminson PD, Rugstad HE. Resistance against cis-dichlorodiamineplatinum in cultured cells with a high content of metallothionein. Toxicol Appl Pharmacol 1981;61:215-26.
46. Tohyama C, Suzuki JS, Hemelraad J, Nishimura N, Nishimura H. Induction of metallothionein and its localization in the nucleus of rat hepatocytes after partial hepatectomy. Hepatology 1993;18:1193-201.
47. Nagel WW, Vallee BL. Cell cycle regulation of metallothionein in human colonic cancer cells. Proc Natl Acad Sci U S A 1995;92:579-83.
48. Woo ES, Lazo JS. Nucleocytoplasmic functionality of metallothionein. Cancer Res 1997;57:4236-41.
49. Öfner D, Maier H, Riedmann B, et al. Immunohistochemical metallothionein expression in colorectal adenocarcinoma: correlation with tumor stage and patient survival. Virchows Arch 1994;425:491-7.
50. Ishikawa T. The ATP-dependent glutathione S-conjugate export pump. Trends Biochem Sci 1992;17:433-8.
51. Ban N, Takahashi Y, Takayama T, et al. Transfection of glutathione S-transferase (GST)-π antisense complementary DNA increase the sensitivity of a colon cancer cell line to adriamycin, cisplatin, melphalan, and etoposide. Cancer Res 1996;56:3577-82.
52. Kantor RR, Giardina SL, Bartolazzi A, et al. Monoclonal antibodies to glutathione S-transferase π-immunohistochemical analysis of human tissues and cancers. Int J Cancer 1991;47:193-201.
53. Ranganathan S, Tew KD. Immunohistochemical localization of glutathione S-transferases-α, μ, and π in normal tissue and carcinomas from human colon. Carcinogenesis 1991;12:2383-7.
54. McKay JA, Murray GI, Weaver RJ, Ewen SW, Melvin WT, Burke MD. Xenobiotic metabolising enzyme expression in colonie neoplasia. Gut 1993;34:1234-9.
55. Mulder TP, Verspaget HW, Sier CF, et al. Glutathione S-transferase-π in colorectal tumors is predictive for overall survival. Cancer Res 1995;55:2696-702.
56. Goldstein LJ, Galski H, Fojo A, et al. Expression of multidrug resistance gene in human cancers. J Natl Cancer Inst 1989;81:116-24.
57. Weinstein RS, Jakate SM, Dominguez JM, et al. Relationship of the expression of the multidrug resistance gene product (P-Glycoprotein) in human colon carcinoma to local tumor aggressiveness and lymph node metastasis. Cancer Res 1991;51:2720-6.
58. Pirker R, Wallner J, Gsur A, et al. MDR1 gene expression in primary colorectal carcinomas. Br J Cancer 1993;68: 691-4.
59. Mikami K, Naito M, Tomida A, Yamada M, Sirakusa T, Tsuruo T. DT-diaphorase as a critical determinant of sensitivity to mitomycin C in human colon and gastric carcinoma cell line. Cancer Res 1996;56:2823-6.
60. Kinsella AR, Smith D, Pickard M. Resistance to chemotherapeutic antimetabolites: a functional of salvage pathway involvement and cellular response to DNA damage. Br J Cancer 1997;75:935-45.
61. Benhattar J, Cerottini JP, Saraga E, Metthez G, Givel J-C. p53 mutations as a possible predictor of response to chemotherapy in metastatic colorectal carcinomas. Int J Cancer 1996;69:190-2.
62. Krajewska M, Moss SF, Krajewski S, Song K, Holt PR, Reed JC. Elevated expression of Bcl-X and reduced Bak in primary colorectal adenocarcinomas. Cancer Res 1996;56:2422-7.
63. Alas MM, Aebi S, Fink D, Howell SB, Los G. Loss of DNA mismatch repair: effect on the rate of mutation to drug resistance. J Natl Cancer Inst 1997;89:1537-41.
64. Satoh M, Cherian G, Imura N, Shimizu H. Modulation of resistance to anticancer drugs by inhibition of metallothionein synthesis. Cancer Res 1994;54:5255-7.
65. Hall A, Robson CN, Hickson ID, Harris AL, Proctor SJ, Cattan AR. Possible role of inhibition of glutathione S-transferase in the partial reversal of chlorambucil resistance by indomethacin in a Chinese hamster ovary cell line. Cancer Res 1989;54:6265-8.
66. Stein U, Walther W, Shoemaker RH. Reversal of multidrug resistance by transduction of cytokine genes into human colon carcinoma cells. J Natl Cancer Inst 1996; 88:1383-92.